Synopsis

Source of validity: Traditional
Rating (out of 5): 1

Pau d'arco (Tabebuia impetiginosa) has a long history of traditional use in South America, particularly in the Amazon region, where indigenous peoples used its inner bark to treat a wide variety of infections, including those believed to be caused by bacteria such as Staphylococcus species. The traditional application often includes making a decoction or tea from the bark, which is consumed orally or used topically on wounds and skin infections.

From a scientific standpoint, laboratory studies have shown that extracts of pau d'arco, particularly its active compounds lapachol and beta-lapachone, possess some antibacterial activity in vitro against various bacteria, including Staphylococcus aureus. However, these effects have been modest and inconsistent, and the concentrations required to inhibit bacterial growth in laboratory settings are often much higher than what is achievable or safe in the human body. Furthermore, there is a lack of robust clinical trials demonstrating efficacy in treating Staph infections in humans. There are also concerns about the potential toxicity of some compounds found in pau d'arco, especially at higher doses.

In summary, the use of pau d'arco for Staph infections is rooted primarily in traditional medicine rather than supported by strong scientific evidence. While some preliminary laboratory findings exist, there is insufficient clinical data to recommend its use for this purpose. Anyone considering its use should consult a healthcare provider due to possible safety concerns.

More about pau d'arco
More about Staph Infections

Other ingredients used for Staph Infections

Other health conditions supported by pau d'arco

Products containing pau d'arco